Fully Automated Software for AMD Screening iPredictTM which utilizes retinal color fundus image and AI based tool

CE Certified - TGA Approved (Australian Health) - MHRA Approved (UK Health) - UAE Health Approved

3000+ patients already screened - currently being used in multiple continents

Age-related Macular Degeneration is one of the foremost causes of blindness among people of 50 years of age

Age-related Macular Degeneration (AMD) is a disease that blurs the sharp central vision needed to see clearly.

Individuals of 50 years of age are at risk of AMD and Blindness Most of the cases are preventable
Diabetic Retinopathy

How does it work?

Data Statistics Data Statistics

Age-Related Macular Degeneration Data and Statistics

Data Statistics
2020
2050
Data Statistics

Direct Cost of Treatment

Most of the cases are preventable. Early diagnosis can save blindness

Changes of cases between 2000 and 2010

As the proportion of people in the U.S. age 65 and older grows larger, more people are developing age-related diseases such as AMD. From 2000-2010, the number of people with AMD grew 18 percent, from 1.75 million to 2.07 million.

Cases of Age-related Macular Degeneration in 2000 and 2010 (in million)

Projections for AMD (2010-2030-2050)

By 2050, the estimated number of people with AMD is expected to grow more than double from 2.07 million to 5.44 million. White Americans will continue to account for the majority of cases. However, Hispanics will see the greatest rate of increase, with a nearly six-fold rise in the number of expected cases from 2010 to 2050.

Projection of Age-related Macular Degeneration in 2030 and 2050 (in million)

Blindness

Age-related Macular Degeneration(AMD), Diabetic Retinopathy (DR) & Glaucoma - the leading causes of blindness

Too Late

no early signs and often too late by the time patient visits Ophthalmologist

No Treatment

to regeneration vision; so, early detection and preventative treatment is the only option

Limited Tools

for early detection - which is the key to start preventative measures

Current Problems of AMD